Page 254 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 254

240     SECTION III  Cardiovascular-Renal Drugs


                 TABLE 14–3  Clinical pharmacologic properties of antiarrhythmic drugs.

                                             Effect on                                       Usefulness in Arrhythmias
                                             AV Nodal
                                  Effect on SA   Refractory        QRS                  Supra-
                  Drug            Nodal Rate  Period   PR Interval  Duration  QT Interval  ventricular  Ventricular  Half-Life
                  Adenosine       ↓↑         ↑↑↑       ↑↑↑         0        0           ++++       ?          <10 s
                  Amiodarone     ↓↓ 1        ↑↑        Variable    ↑        ↑↑↑↑        +++        +++        (weeks)
                  Diltiazem      ↑↓          ↑↑        ↑           0        0           +++        -          4–8 h
                  Disopyramide   ↑↓ 1,2      ↑↓ 2      ↑↓ 2        ↑↑       ↑↑          +          +++        7–8 h
                  Dofetilide     ↓(?)        0         0           0        ↑↑          ++         None       7 h
                  Dronedarone                                               ↑           +++        -          24 h
                  Esmolol        ↓↓          ↑↑        ↑↑          0        0           +          +          10 min
                  Flecainide     None,↓      ↑         ↑           ↑↑↑      0           + 3        ++++       20 h
                  Ibutilide      ↓(?)        0         0           0        ↑↑          ++         ?          6 h
                  Lidocaine      None 1      None      0           0        0           None 4     +++        1–2 h
                  Mexiletine     None 1      None      0           0        0           None       +++        8–20 h
                  Procainamide   ↓ 1         ↑↓ 2      ↑↓ 2        ↑↑       ↑↑          +          +++        3–4 h
                  Propafenone    0, ↓        ↑         ↑           ↑↑↑      0           +          +++        5–7 h
                  Propranolol    ↓↓          ↑↑        ↑↑          0        0           +          +          5 h
                  Quinidine      ↑↓ 1,2      ↑↓ 2      ↑↓ 2        ↑↑       ↑↑          +          +++        6 h
                  Sotalol        ↓↓          ↑↑        ↑↑          0        ↑↑↑         +++        +++        7–12 h
                  Verapamil      ↓↓          ↑↑        ↑↑          0        0           +++        -          7 h
                  Vernakalant                ↑         ↑                                +++        -          2 h
                 1 May suppress diseased sinus nodes.
                 2
                 Anticholinergic effect and direct depressant action.
                 3 Especially in Wolff-Parkinson-White syndrome.
                 4
                 May be effective in atrial arrhythmias caused by digitalis.

                 QUINIDINE (SUBGROUP 1A)                             Extracardiac Effects

                                                                     Adverse GI effects of diarrhea, nausea, and vomiting are observed
                 Cardiac Effects                                     in one third to one half of patients. A syndrome of headache,
                 Quinidine has actions similar to those of procainamide: it slows   dizziness, and tinnitus  (cinchonism) is observed at toxic drug
                 the upstroke of the action potential, slows conduction, and   concentrations. Idiosyncratic or immunologic reactions, including
                 prolongs the QRS duration of the ECG, by blockade of sodium   thrombocytopenia, hepatitis, angioneurotic edema, and fever, are
                 channels. The drug also prolongs the action potential duration by   observed rarely.
                 blockade of several potassium channels. Its toxic cardiac effects
                 include excessive QT-interval  prolongation  and  induction of   Pharmacokinetics & Therapeutic Use
                 torsades de pointes arrhythmia. Toxic concentrations of quinidine   Quinidine is readily absorbed from the GI tract and eliminated
                 also produce excessive sodium channel blockade with slowed con-  by hepatic metabolism. It is rarely used because of cardiac and
                 duction throughout the heart. It also has modest antimuscarinic   extracardiac adverse effects and the availability of better-tolerated
                 actions in the heart.
                                                                     antiarrhythmic drugs.
                                O  CH 3
                                                                     DISOPYRAMIDE (SUBGROUP 1A)

                                    H     N                          Cardiac Effects
                         N          C              CH  CH 2          The effects of disopyramide are very similar to those of procain-
                                    OH                               amide and quinidine. Its cardiac antimuscarinic effects are even
                                      Quinidine                      more marked than those of quinidine. Therefore, a drug that slows
   249   250   251   252   253   254   255   256   257   258   259